The latest on Methuselah, health span research, and regenerative medicine
A few weeks ago, cell rejuvenation company Turn Biotechnologies announced that it had completed an oversubscribed fundraising round. While that is noteworthy, what really caught our attention was the list of organizations participating in the round.
Read MoreSkeptics of cellular regeneration often encourage researchers to slow down and be cautious. They say there is much we don’t know about the science – even, that it may be dangerous. But that science is incredibly promising. While much research remains to done, we would hate for excessive caution to needlessly delay scientific progress. Many researchers are working on cellular regeneration.
Read MoreAn Endpoints News story recently explored a seeming disconnect between Altos Labs’ stated goals and what one of its noted researchers, Juan Carlos Izpisua, told the Spanish newspaper El Pais. He said that the world will be able to “predict, prevent and treat diseases and aging” within two decades.
Read More
